PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AngioDynamics, Inc. (ANGO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS03475V1017
CUSIP03475V101
SectorHealthcare
IndustryMedical Instruments & Supplies

Highlights

Market Cap$213.62M
EPS-$0.36
PE Ratio41.40
PEG Ratio1.87
Revenue (TTM)$329.54M
Gross Profit (TTM)$174.25M
EBITDA (TTM)$4.57M
Year Range$5.27 - $12.62
Target Price$14.00
Short %7.40%
Short Ratio5.79

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ANGO

AngioDynamics, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in AngioDynamics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%OctoberNovemberDecember2024FebruaryMarch
-54.40%
368.08%
ANGO (AngioDynamics, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

AngioDynamics, Inc. had a return of -27.30% year-to-date (YTD) and -54.03% in the last 12 months. Over the past 10 years, AngioDynamics, Inc. had an annualized return of -9.51%, while the S&P 500 had an annualized return of 10.96%, indicating that AngioDynamics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-27.30%10.04%
1 month-2.40%3.53%
6 months-21.27%22.79%
1 year-54.03%32.16%
5 years (annualized)-24.30%13.15%
10 years (annualized)-9.51%10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-24.74%-6.95%
2023-7.59%-8.97%-15.18%5.32%20.06%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for AngioDynamics, Inc. (ANGO) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ANGO
AngioDynamics, Inc.
-1.02
^GSPC
S&P 500
2.76

Sharpe Ratio

The current AngioDynamics, Inc. Sharpe ratio is -1.02. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-1.02
2.76
ANGO (AngioDynamics, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


AngioDynamics, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-81.65%
0
ANGO (AngioDynamics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AngioDynamics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AngioDynamics, Inc. was 83.04%, occurring on Mar 25, 2024. The portfolio has not yet recovered.

The current AngioDynamics, Inc. drawdown is 81.65%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-83.04%May 1, 20064506Mar 25, 2024
-39.87%Jun 30, 200479Oct 21, 200425Nov 26, 2004104
-32.65%Jan 10, 200568Apr 18, 200558Jul 11, 2005126
-29.08%Jul 19, 200561Oct 12, 200559Jan 6, 2006120
-25.69%Jan 27, 200631Mar 13, 200614Mar 31, 200645

Volatility

Volatility Chart

The current AngioDynamics, Inc. volatility is 11.79%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%OctoberNovemberDecember2024FebruaryMarch
11.79%
2.82%
ANGO (AngioDynamics, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AngioDynamics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items